IMC-A12 (cixutumumab)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IMC-A12 (cixutumumab), covering 2014-06-19 to 2018-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy [Phase 2]